Adverse Event Clinical Research, published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.0.1 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/fhir-ae-research-ig/ and changes regularly. See the Directory of published versions
Page standards status: Informative |
<MedicationRequest xmlns="http://hl7.org/fhir">
<id value="medication-request-example-kadcyla"/>
<text>
<status value="generated"/>
<div xmlns="http://www.w3.org/1999/xhtml"><p><b>Generated Narrative: MedicationRequest</b><a name="medication-request-example-kadcyla"> </a><a name="hcmedication-request-example-kadcyla"> </a></p><div style="display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%"><p style="margin-bottom: 0px">Resource MedicationRequest "medication-request-example-kadcyla" </p></div><p><b>status</b>: active</p><p><b>intent</b>: order</p><h3>Medications</h3><table class="grid"><tr><td style="display: none">-</td><td><b>Concept</b></td></tr><tr><td style="display: none">*</td><td>KADCYLA <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="http://terminology.hl7.org/5.5.0/CodeSystem-v3-rxNorm.html">RxNorm</a>#1371046)</span></td></tr></table><p><b>subject</b>: <a href="Patient-patient-example-kaitlyn-b.html">Patient/patient-example-kaitlyn-b</a> " BOUNCE"</p><p><b>authoredOn</b>: 2020-03-12</p><p><b>requester</b>: <a href="Practitioner-practitioner-owen-oncologist.html">Practitioner/practitioner-owen-oncologist</a> " ONCOLOGIST"</p><blockquote><p><b>dosageInstruction</b></p><p><b>text</b>: Kadcyla IV at 3.6mg</p><p><b>timing</b>: Starting 2020-04-01, Once</p><p><b>route</b>: Intravenous route (qualifier value) <span style="background: LightGoldenRodYellow; margin: 4px; border: 1px solid khaki"> (<a href="https://browser.ihtsdotools.org/">SNOMED CT</a>#47625008)</span></p><blockquote><p><b>doseAndRate</b></p></blockquote><p><b>maxDosePerAdministration</b>: 1</p></blockquote></div>
</text>
<status value="active"/>
<intent value="order"/>
<medication>
<concept>
<coding>
<system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
<code value="1371046"/>
<display value="KADCYLA"/>
</coding>
</concept>
</medication>
<subject>🔗
<reference value="Patient/patient-example-kaitlyn-b"/>
</subject>
<authoredOn value="2020-03-12"/>
<requester>🔗
<reference value="Practitioner/practitioner-owen-oncologist"/>
</requester>
<dosageInstruction>
<text value="Kadcyla IV at 3.6mg"/>
<timing>
<repeat>
<boundsPeriod>
<start value="2020-04-01"/>
</boundsPeriod>
</repeat>
</timing>
<route>
<coding>
<system value="http://snomed.info/sct"/>
<code value="47625008"/>
<display value="Intravenous route (qualifier value)"/>
</coding>
</route>
<doseAndRate>
<rateQuantity>
<value value="3.6"/>
<unit value="mg"/>
<system value="http://unitsofmeasure.org"/>
<code value="mg"/>
</rateQuantity>
</doseAndRate>
<maxDosePerAdministration>
<value value="1"/>
</maxDosePerAdministration>
</dosageInstruction>
</MedicationRequest>